Abstract
In this paper we set out to explore the enactments of risk by clinicians involved in the development of stem cell therapy for liver disease. In the process, we contribute to a performative re-thinking of how ‘risk’ can be analytically treated in relation to health. The bulk of the paper, drawing on interview data, is concerned with how clinicians’ accounts about the risks entailed in their research-oriented work performatively ‘make’ clinicians themselves, but also various other ‘constituencies’ – notably, publics and regulatory actors, and also such diverse ‘entities’ as scientific rigour and ethics. We trace the ways in which they enact the complexities of taking risks in the context of public demands, regulatory constraints, and resource limitation and explore how clinicians tend to represent themselves as caught between the ‘rock of courage’ and the ‘hard place of caution’.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alison, M.R., R. Poulsom, R. Jeffery, A.P. Dhillon, A. Quaglia, J. Jacob, et al. 2000. Hepatocytes from Non-hepatic Stem Cells. Nature 406: 257.
Alison, M.R., M.J. Lovell, N.C. Direkze, N.A. Wright, and R. Poulsom. 2006. Stem Cell Plasticity and Tumour Formation. European Journal of Cancer 42 (9): 1247–1256.
Beck, U. 1992. The Risk Society. London: Sage.
Blau, H.M., T.R. Brazelton, and J.M. Weimann. 2001. The Evolving Concept of a Stem Cell: Entity or Function. Cell 105: 829–841.
Bourdieu, P. 1984. Distinction: A Social Critique of the Judgement of Taste. London: Routledge.
Brown, N., and M. Michael. 2002. From Authority to Authenticity: The Changing Governance of Biotechnology. Health, Risk & Society 4: 259–272.
Burns, C.J., S.J. Persaud, and P.M. Jones. 2004. Stem Cell Therapy for Diabetes: Do We Need to Make Beta Cells? Endocrinology 183 (3): 437–443.
Calne, R.Y. 1998. The Ultimate Gift: The Story of Britain’s Premier Transplant Surgeon. London: Headline.
———. 2003. The History of Liver Transplantation. In History of Organ and Cell Transplantation, ed. N.S. Hakim and V.E. Papalois, 100–119. London: Imperial College Press.
Calne, R.Y., and R. Williams. 1968. Liver Transplantation in Man- I. Observations on Technique and Organisation in 5 Cases. British Medical Journal 280: 535–540.
Cameron, J.S. 2002. History of the Treatment of Renal Failure by Dialysis. Oxford: Oxford University Press.
Clarke, A.E., J.K. Shim, L. Mamo, J.R. Fosket, and J.R. Fishman. 2003. Biomedicalization: Technoscientific Transformations of Health, Illness, and US Biomedicine. American Sociological Review 68: 161–194.
Dahlke, M.H., F.C. Popp, S. Larsen, H.J. Schlitt, and J.E.J. Rasko. 2004. Stem Cell Therapy of the Liver – Fusion or Fiction? Liver Transplantation 10: 471–479.
Department of Health. 2005. UK Stem Cell Initiative: [Pattison] Report & Recommendations.
Donovan, P.J., and J. Gearhart. 2001. The End of the Beginning for Pluripotent Stem Cells. Nature 414: 92–97.
Douglas, M. 1970. Natural Symbols: Explorations in Cosmology. New York: Pantheon.
Evans, M.J., and M.H. Kaufman. 1981. Establishment in Culture of Pluripotent Stem Cells from Mouse Embryos. Nature 292: 154–156.
Fausto, N. 2004. Liver Regeneration and Repair: Hepatocytes, Progenitor Cells, and Stem Cells. Hepatology 39: 1477–1487.
Forsythe, J.L.R., ed. 2001. Transplantation Surgery: Current Dilemmas. Philadelphia: Saunders.
Fox, R.C. 1998. Experiment Perilous Physicians and Patients Facing the Unknown. New Brunswick: Transaction.
Fox, R.C., and J.P. Swazey. 2002. The Courage to Fail: A Social View of Organ Transplants and Dialysis. 3rd ed. New Brunswick: Transaction.
Franklin, S. 2001. Culturing Biology: Cell Lines for the Second Millennium. Health 5: 335–354.
———. 2005. Stem Cells R Us: Emergent Life Forms and the Global Biological. In Global Assemblages: Technology, Politics and Ethics as Anthropological Problems, ed. A. Ong and S.J. Collier. New York: Blackwell.
Gearhart, J. 1998. New Potential for Human Embryonic Stem Cells. Science 282: 1061–1062.
Gearhart, J., ed. 2005. Stem Cells: Nuclear Reprogramming and Therapeutic Applications. Novartis Foundation Symposium. New York: Wiley.
Grompe, M. 2004. The Importance of Knowing Your Identity: Sources of Confusion in Stem Cell Biology. Hepatology 39: 35–37.
Hacking, I. 1986. Making Up People. In Reconstructing individualism, ed. T.C. Heller, M. Sosna, and D.E. Wellberg. Stanford: Stanford University Press.
Hamilton, C., S. Adolphs, and B. Nerlich. 2007. The Meanings of ‘Risk’: A View from Corpus Linguistics. Discourse & Society 18: 163–181.
Jasanoff, S. 2005. Designs on Nature: Science and Democracy in Europe and the United States. Princeton: Princeton University Press.
Johnson, B.B. 1987. The Environmentalist Movement and Grid/Group Analysis: A Modest Critique. In The Social Construction of Risk, ed. B.V. Covello and B. Johnson. Dordrecht: Reidel.
Keating, P., and A. Cambrosio. 2003. Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth Century Medicine. Cambridge: MIT Press.
Kitzinger, J., and C. Williams. 2005. Forecasting Science Futures: Legitimising Hope and Calming Fears in the Embryo Stem Cell Debate. Social Science & Medicine 61: 731–740.
Lanza, R., H. Blau, J. Gearhart, B. Hogan, D. Melton, M. Moore, et al., eds. 2004. Handbook of Stem Cells, Volume 1 Embryonic Stem Cells. Amsterdam: Elsevier.
Lock, M. 2001. Twice Dead: Organ Transplants and the Reinvention of Death. Berkeley: University of California Press.
Lupton, D. 1999. Risk. London: Routledge.
Michael, M., and N. Brown. 2005. Scientific Citizenships: Self-Representations of Xenotransplantation’s Publics. Science as Culture 14 (1): 38–57.
Michael, M., S.P. Wainwright, C. Williams, B. Farsides, and A. Cribb. 2007a. From Core Set to Assemblage: On the Dynamics of Exclusion and Inclusion in the Failure to Derive Beta Cells from Embryonic Stem Cells. Science Studies 20: 5–25.
Michael, M., S.P. Wainwright, and C. Williams. 2007b. Temporality and Prudence: On Stem Cells as ‘Phronesic Things’. Configurations 13: 373–394.
Mitry, R., and A. Dhawan. 2002. Hepatocyte Transplantation from Bench to Bedside. British Inherited Metabolic Disease Group Bulletin, Autumn, 1–4.
Mol, A. 2002. The Body Multiple. Ontology in Medical Practice. Durham: Duke University Press.
Nightingale, P., and P. Martin. 2004. The Myth of the Biotech Revolution. Trends in Biotechnology 22: 563–569.
Norman, D.J., and L.A. Turka. 2001. Primer on Transplantation: Manual of the American Society of Transplantation. 2nd ed. Oxford: Blackwell Science.
O’Grady, J., J. Lake, and P. Howdel. 2006. Comprehensive Clinical Hepatology. 2nd ed. St Louis: Mosby.
Parry, S. 2003. The Politics of Cloning: Mapping the Rhetorical Convergence of Embryos and Stem Cells in Parliamentary Debates. New Genetics & Society 22: 145–168.
Plevris, J.N., and P.C. Hayes. 2001. Bioengineering as an Alternative to Liver Transplantation. In Transplantation Surgery: Current Dilemmas, ed. J.L.R. Forsythe. Philadelphia: Saunders.
Pickering, S.J., P.R. Braude, M. Patel, C.J. Burns, J. Trussler, V. Bolton, and S. Minger. 2003. Preimplantation Genetic Diagnosis as a Novel Source of Embryos for Stem Cell Research. Reproductive Biomedicine Online 7 (3): 353–364.
Polak, J.M., L.L. Hench, and P. Kemp. 2002. Future Strategies for Tissue and Organ Replacement. London: Imperial College Press.
Rajan, K.S. 2006. Biocapital: The Constitution of Postgenomic Life. Durham: Duke University Press.
Rayner, S. 1986. Management of Radiation Hazards in Hospitals: Plural Rationalities in a Single Institution. Social Studies of Science 16: 573–591.
Rose, N. 2007. The Politics of Life Itself. Princeton: Princeton University Press.
Sargent, S., and S.P. Wainwright. 2006. Quality of Life Following Emergency Liver Transplantation for Acute Liver Failure. Nursing in Critical Care 11: 168–176.
Schwarz, M., and M. Thompson. 1990. Divided We Stand. Hemel Hempstead: Harvester Wheatsheaf.
Scott, C.T. 2006. Stem Cell Now: From the Experiment That Shook the World to the New Politics of Life. New York: Pi Press.
Seldon, C., and H. Hodgson. 2002. Engineering the Liver. In Future Strategies for Tissue and Organ Replacement, ed. J.M. Polak, L.L. Hench, and P. Kemp. London: Imperial College Press.
Starzl, T.E. 2003. The Puzzle People: Memoirs of a Transplant Surgeon. Pittsburgh: University of Pittsburgh Press.
Starzl, T.E., T.L. Marchioro, K.N. Von Kaulla, G. Hermann, R.S. Brittain, and W.R. Waddell. 1963. Homotransplantation of the Liver in Humans. Surgery Gynecology & Obstetrics 117: 659–665.
Strauss, A.L. 1987. Qualitative Analysis for Social Scientists. Cambridge: Cambridge University Press.
Suknikh, G.T., and A. Shitl. 2003. Stem Cell Transplantation for Treatment of Liver Diseases. International Journal of Molecular Medicine 11: 395–400.
Theise, N. 2003. Liver Stem Cells: The Rise and Fall of Tissue Biology. Hepatology 38: 804–806.
Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, et al. 1998. Embryonic Stem Cell Lines Derived from Human Blastocysts. Science 282: 1145–1147.
Tulloch, J., and D. Lupton. 2003. Risk and Everyday Life. London: Sage.
Wainwright, S.P. 1994. Recovery from Liver Transplantation: A Literature Review. Journal of Advanced Nursing 20: 861–869.
———. 1995. The Transformational Experience of Liver Transplantation. Journal of Advanced Nursing 22: 1068–1076.
———. 1997. Transcending Chronic Liver Disease: A Qualitative Study. Journal of Clinical Nursing 6: 43–53.
Wainwright, S.P., and D. Gould. 1997. Non-adherence with Medications in Organ Transplant Patients: A Literature Review. Journal of Advanced Nursing 26: 968–977.
Wainwright, S.P., C. Williams, M. Michael, B. Farsides, and A. Cribb. 2006a. From Bench to Bedside? Biomedical Scientists’ Expectations of Stem Cell Science as a Future Therapy for Diabetes. Social Science & Medicine 63: 2052–2064.
———. 2006b. Ethical Boundary Work in the Embryonic Stem Cell Laboratory. Sociology of Health & Illness 28: 732–748.
Wainwright, S.P., C. Williams, S.J. Persaud, and P.M. Jones. 2006c. Real Science, Biological Bodies and Stem Cells: Constructing Images of Beta Cells in the Biomedical Science Lab. Social Theory & Health 4: 275–298.
Wainwright, S., C. Williams, M. Michael, B. Farsides, and A. Cribb. 2006d. Ethical Boundary Work in the Embryonic Stem Cell Laboratory. Sociology of Health & Illness 28: 732–748.
Wainwright, S.P., C. Williams, M. Michael, B. Farsides, and A. Cribb. 2007. Remaking the Body? Scientists’ Genetic Discourses and Practices as Examples of Changing Expectations on Embryonic Stem Cell Therapy for Diabetes. New Genetics & Society 26: 251–268.
Waldby, C. 2002. Stem Cells, Tissue Cultures and the Production of Biovalue. Health 6: 305–323.
Weber, R. 1990. Basic Content Analysis. London: Sage.
Williams, C., J. Kitzinger, and L. Henderson. 2003. Envisaging the Embryo in Stem Cell Research: Discursive Strategies and Media Reporting of the Ethical Debates. Sociology of Health & Illness 25: 793–814.
Williams, C., S.P. Wainwright, K. Ehrich, and M. Michael. 2008. Human Embryos as Boundary Objects? Some Reflections on the Biomedical Worlds of Embryonic Stem Cells and Pre-implantation Genetic Diagnosis. New Genetics & Society 27: 7–18.
Acknowledgements
This paper is based on two research projects: ESRC Stem Cell Initiative RES-340-25-0003 and RES-350-27-0001.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Wainwright, S., Michael, M., Williams, C. (2018). Performing Risk & Ethics in Clinicians’ Accounts of Stem Cell Liver Therapies. In: Riesch, H., Emmerich, N., Wainwright, S. (eds) Philosophies and Sociologies of Bioethics. Springer, Cham. https://doi.org/10.1007/978-3-319-92738-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-92738-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92737-4
Online ISBN: 978-3-319-92738-1
eBook Packages: Religion and PhilosophyPhilosophy and Religion (R0)